Basecamp Research Valuation, Funding & Investors

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

ZSPepLib is a peptide drug discovery platform company established in January 2017 and based in Zhuzhou, Hunan province, China. The firm specializes in large-scale peptide libraries for lead compound screening, custom peptide synthesis, and R&D services targeting therapeutic development in oncology and metabolic diseases.

BioRender is a Toronto-headquartered web platform enabling scientists in pharmaceuticals and life sciences to create publication-ready figures and illustrations. Launched in 2018, it hosts over 50,000 customizable icons across biology, chemistry, and medicine, used by more than 10 million researchers at institutions like Harvard, Pfizer, and Novartis. The tool supports collaborative editing, exports in vector formats for journals such as Nature and Cell, and integrates with lab notebooks, streamlining communication with consistent visual standards.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Angiocrine Bioscience is a New York-based biotechnology firm advancing stem cell expansion technologies. Its endothelial cell platform mimics the vascular niche to amplify hematopoietic stem cells ex vivo without serum or cytokines. Applications span regenerative medicine, cell therapies for blood disorders, and tissue engineering in human and mouse models.

Collate is a San Francisco-based platform leveraging artificial intelligence to automate documentation for drug development, medical devices, and diagnostics firms. It generates regulatory submissions, clinical protocols, and quality management documents from concept through commercialization, reducing preparation time by integrating with tools like Veeva and MasterControl. Serving life sciences companies worldwide, Collate ensures compliance with FDA, EMA, and ISO standards while streamlining collaborative authoring. Launched in 2022, the platform processes thousands of documents annually for biotech and medtech innovators.

Immunai is a biotechnology company with locations in New York City, San Francisco, and Tel Aviv, mapping the immune system using single-cell genomics and machine learning. The firm profiles hundreds of immune cell types from blood samples via its proprietary database, aiding biomarker discovery for therapeutics in autoimmune diseases and cancer.

Mammoth Biosciences is a biotechnology company, co-founded by CRISPR pioneer Jennifer Doudna, that develops CRISPR-based tools for diagnostics and gene-editing therapeutics. Its platform is built around compact Cas proteins such as Cas14 and Casφ, which the company applies to in vivo gene editing for genetic and infectious diseases as well as decentralized disease detection. Mammoth has partnered with organizations including Regeneron, GSK, and the NIH, and has received government funding to develop COVID-19 testing technology.

Nordic Bioscience is a Herlev-based biotech company specializing in extracellular matrix biomarkers. Its Protein Fingerprint technology develops blood assays for diseases like osteoporosis and fibrosis. The GCLP-accredited lab runs clinical trials under CAP standards and ISO 9001 certification, partnering with pharma firms globally.

Element Biosciences is a San Diego-based life sciences company building next-generation DNA sequencing instruments. The AVITI platform delivers high-accuracy reads using avidity sequencing chemistry, reducing costs through improved signal-to-noise ratios in surface chemistry and biochemistry. Launched in 2022, it supports workflows from short-read to long-read applications for genomics research. Element Biosciences serves academic labs, biopharma, and clinical sequencing markets worldwide.

Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.

DNAnexus is a Mountain View-headquartered cloud platform for genomic data management and analysis. Founded in 2009, the company supports petabyte-scale storage, HIPAA-compliant collaboration, and AI workflows for clients including the Broad Institute, Illumina, and NHS Genomics England. DNAnexus operates data centers in the US, Europe, and Asia, powering projects like the UK Biobank analysis and COVID-19 surveillance. Its Apollo system enables secure multi-tenant research across 100,000 genomes.

GeneMind Biosciences produces third-generation single-molecule gene sequencing systems, delivering advanced tools for clinicians and researchers through ongoing technological breakthroughs.

Inscripta is a Boulder, Colorado-based gene-editing technology company, founded in 2015, that builds tools for genome engineering used in food, fuel, and healthcare applications. Its flagship product, the Onyx platform, is a benchtop system for digital microbial genome engineering that automates identifying genomic pathways, compiling them into libraries, editing them at scale with CRISPR-based tools such as the MAD7 nuclease, and analyzing the resulting effects, all within a single integrated workflow. Early commercial customers have included the University of Liverpool's GeneMill, which uses the platform to provide synthetic biology services to life-sciences and pharmaceutical partners.

SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.